Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection - 2Step by step instructions to Shield Your Wellbeing Around 5G Pinnacles\
- 3A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
- 4‘Harry Potter and the Philosopher’s Stone’ trailer is raising eyebrows among Potterheads: ‘Where’s the whimsical color?’
- 5Vote In favor of Feasible Way You Prescribe to Shop for Garments
- What's Your Number one Superhuman Film Made?
- Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It
- Figure out How to Explore Land Close to 5G Pinnacles
- Coca-Cola Co. and bottlers to invest in South Africa operations
- Remarkable Spots for Hot Air Swelling All over The Planet
- Top 10 Arising Advances That Will Shape What's in store
- Former biotech CEO sued over COVID vaccine alleged insider trading
- How to watch 'A Charlie Brown Christmas' for free in 2025
- This Is Canada's Only Province Without Any Bears
